INO Therapeutics Overview

  • Status
  • Acquired/​Merged

  • Employees
  • 463

Employees

  • Latest Deal Type
  • IPO
  • (Cancelled)

  • Financing Rounds
  • 2

INO Therapeutics General Information

Description

Manufacturer of late stage drugs for the treatment of heart and lung functions. The company's primary offering INOmax is used to carry oxygenated blood to the body tissues, and for the treatment of persistant pulmonary hypertension in the newborn.

Contact Information

Website
www.inotherapeutics.com
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • Six State Route 173
  • Clinton, NJ 08809
  • United States
+1 (908)
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Acquirer
Ikaria
Vertical(s)
Manufacturing, Life Sciences
Corporate Office
  • Six State Route 173
  • Clinton, NJ 08809
  • United States
+1 (908)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

INO Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore INO Therapeutics‘s full profile, request access.

Request a free trial

INO Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

INO Therapeutics Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore INO Therapeutics‘s full profile, request access.

Request a free trial

INO Therapeutics FAQs

  • Where is INO Therapeutics headquartered?

    INO Therapeutics is headquartered in Clinton, NJ.

  • What is the size of INO Therapeutics?

    INO Therapeutics has 463 total employees.

  • What industry is INO Therapeutics in?

    INO Therapeutics’s primary industry is Pharmaceuticals.

  • Is INO Therapeutics a private or public company?

    INO Therapeutics is a Private company.

  • What is the current valuation of INO Therapeutics?

    The current valuation of INO Therapeutics is .

  • What is INO Therapeutics’s current revenue?

    The current revenue for INO Therapeutics is .

  • Who are INO Therapeutics’s investors?

    Linde has invested in INO Therapeutics.

  • When was INO Therapeutics acquired?

    INO Therapeutics was acquired on 12-Nov-2010.

  • Who acquired INO Therapeutics?

    INO Therapeutics was acquired by Ikaria.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »